Cargando…
Comparison of Intraperitoneal Bupivacaine and Intravenous Ketorolac for Postoperative Pain Management Following Laparoscopic Cholecystectomy
BACKGROUND: Postoperative pain following laparoscopic cholecystectomy (LC) arises from incision sites and residual intraperitoneal CO(2) gas. Opioids as a class of pain-relieving drugs are broadly used to control pain after LC; however, these drugs can cause various side effects. OBJECTIVES: The pur...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Briefland
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8909541/ https://www.ncbi.nlm.nih.gov/pubmed/35291402 http://dx.doi.org/10.5812/aapm.114623 |
_version_ | 1784666197921366016 |
---|---|
author | Arabzadeh, AmirAhmad Seyedsadeghi, Mirsalim Sadeghi, Nahideh Nejati, Kazem Mohammadian Erdi, Ali |
author_facet | Arabzadeh, AmirAhmad Seyedsadeghi, Mirsalim Sadeghi, Nahideh Nejati, Kazem Mohammadian Erdi, Ali |
author_sort | Arabzadeh, AmirAhmad |
collection | PubMed |
description | BACKGROUND: Postoperative pain following laparoscopic cholecystectomy (LC) arises from incision sites and residual intraperitoneal CO(2) gas. Opioids as a class of pain-relieving drugs are broadly used to control pain after LC; however, these drugs can cause various side effects. OBJECTIVES: The purpose of this study was to compare the efficacy of intraperitoneal injection of bupivacaine with that of intravenous ketorolac in managing postoperative pain in patients who had undergone LC. METHODS: This randomized, double-blind clinical trial was carried out on patients who had undergone LC. Ninety patients who had undergone elective LC were randomly divided into 3 groups (n = 30 for each group). Group A received 40 mL of 0.25% bupivacaine solution intraperitoneally at the end of the operation; group B received 30 mg of ketorolac intravenously 30 minutes before surgery and every 8 hours after surgery, and patients in group C received normal saline intraperitoneally and intravenous injection. The patients were postoperatively assessed for Visual Analog Scale (VAS) scores, postoperative opioid consumption, shoulder pain, side effects (sedation, nausea, and vomiting), and satisfaction. The data were analyzed using SPSS. P values < 0.05 were considered significant. RESULTS: The intraperitoneal injection of bupivacaine and intravenous injection of ketorolac were significantly effective in reducing postoperative abdominal pain, shoulder pain, and incidence of nausea and vomiting compared to the placebo group (P < 0.001). Although intraperitoneal bupivacaine and intravenous ketorolac had no significant difference in pain relief compared with each other, patients in both bupivacaine and ketorolac groups were significantly more satisfied with their analgesia compared to the control group (P < 0.001). CONCLUSIONS: Intraperitoneal injection of bupivacaine and intravenous injection of ketorolac both are safe and effective methods to control pain, nausea, and vomiting after LC. |
format | Online Article Text |
id | pubmed-8909541 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | Briefland |
record_format | MEDLINE/PubMed |
spelling | pubmed-89095412022-03-14 Comparison of Intraperitoneal Bupivacaine and Intravenous Ketorolac for Postoperative Pain Management Following Laparoscopic Cholecystectomy Arabzadeh, AmirAhmad Seyedsadeghi, Mirsalim Sadeghi, Nahideh Nejati, Kazem Mohammadian Erdi, Ali Anesth Pain Med Research Article BACKGROUND: Postoperative pain following laparoscopic cholecystectomy (LC) arises from incision sites and residual intraperitoneal CO(2) gas. Opioids as a class of pain-relieving drugs are broadly used to control pain after LC; however, these drugs can cause various side effects. OBJECTIVES: The purpose of this study was to compare the efficacy of intraperitoneal injection of bupivacaine with that of intravenous ketorolac in managing postoperative pain in patients who had undergone LC. METHODS: This randomized, double-blind clinical trial was carried out on patients who had undergone LC. Ninety patients who had undergone elective LC were randomly divided into 3 groups (n = 30 for each group). Group A received 40 mL of 0.25% bupivacaine solution intraperitoneally at the end of the operation; group B received 30 mg of ketorolac intravenously 30 minutes before surgery and every 8 hours after surgery, and patients in group C received normal saline intraperitoneally and intravenous injection. The patients were postoperatively assessed for Visual Analog Scale (VAS) scores, postoperative opioid consumption, shoulder pain, side effects (sedation, nausea, and vomiting), and satisfaction. The data were analyzed using SPSS. P values < 0.05 were considered significant. RESULTS: The intraperitoneal injection of bupivacaine and intravenous injection of ketorolac were significantly effective in reducing postoperative abdominal pain, shoulder pain, and incidence of nausea and vomiting compared to the placebo group (P < 0.001). Although intraperitoneal bupivacaine and intravenous ketorolac had no significant difference in pain relief compared with each other, patients in both bupivacaine and ketorolac groups were significantly more satisfied with their analgesia compared to the control group (P < 0.001). CONCLUSIONS: Intraperitoneal injection of bupivacaine and intravenous injection of ketorolac both are safe and effective methods to control pain, nausea, and vomiting after LC. Briefland 2021-12-27 /pmc/articles/PMC8909541/ /pubmed/35291402 http://dx.doi.org/10.5812/aapm.114623 Text en Copyright © 2021, Author(s) https://creativecommons.org/licenses/by-nc/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/ (https://creativecommons.org/licenses/by-nc/4.0/) ) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited. |
spellingShingle | Research Article Arabzadeh, AmirAhmad Seyedsadeghi, Mirsalim Sadeghi, Nahideh Nejati, Kazem Mohammadian Erdi, Ali Comparison of Intraperitoneal Bupivacaine and Intravenous Ketorolac for Postoperative Pain Management Following Laparoscopic Cholecystectomy |
title | Comparison of Intraperitoneal Bupivacaine and Intravenous Ketorolac for Postoperative Pain Management Following Laparoscopic Cholecystectomy |
title_full | Comparison of Intraperitoneal Bupivacaine and Intravenous Ketorolac for Postoperative Pain Management Following Laparoscopic Cholecystectomy |
title_fullStr | Comparison of Intraperitoneal Bupivacaine and Intravenous Ketorolac for Postoperative Pain Management Following Laparoscopic Cholecystectomy |
title_full_unstemmed | Comparison of Intraperitoneal Bupivacaine and Intravenous Ketorolac for Postoperative Pain Management Following Laparoscopic Cholecystectomy |
title_short | Comparison of Intraperitoneal Bupivacaine and Intravenous Ketorolac for Postoperative Pain Management Following Laparoscopic Cholecystectomy |
title_sort | comparison of intraperitoneal bupivacaine and intravenous ketorolac for postoperative pain management following laparoscopic cholecystectomy |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8909541/ https://www.ncbi.nlm.nih.gov/pubmed/35291402 http://dx.doi.org/10.5812/aapm.114623 |
work_keys_str_mv | AT arabzadehamirahmad comparisonofintraperitonealbupivacaineandintravenousketorolacforpostoperativepainmanagementfollowinglaparoscopiccholecystectomy AT seyedsadeghimirsalim comparisonofintraperitonealbupivacaineandintravenousketorolacforpostoperativepainmanagementfollowinglaparoscopiccholecystectomy AT sadeghinahideh comparisonofintraperitonealbupivacaineandintravenousketorolacforpostoperativepainmanagementfollowinglaparoscopiccholecystectomy AT nejatikazem comparisonofintraperitonealbupivacaineandintravenousketorolacforpostoperativepainmanagementfollowinglaparoscopiccholecystectomy AT mohammadianerdiali comparisonofintraperitonealbupivacaineandintravenousketorolacforpostoperativepainmanagementfollowinglaparoscopiccholecystectomy |